Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Cash from Operations: 2011-2025

Historic Cash from Operations for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $29.3 million.

  • Mimedx Group's Cash from Operations rose 49.45% to $29.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.8 million, marking a year-over-year increase of 17.72%. This contributed to the annual value of $67.1 million for FY2024, which is 92.14% up from last year.
  • Latest data reveals that Mimedx Group reported Cash from Operations of $29.3 million as of Q3 2025, which was up 103.41% from $14.4 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Cash from Operations registered a high of $29.3 million during Q3 2025, and its lowest value of -$11.1 million during Q4 2021.
  • Its 3-year average for Cash from Operations is $13.7 million, with a median of $14.4 million in 2025.
  • As far as peak fluctuations go, Mimedx Group's Cash from Operations plummeted by 287.93% in 2022, and later skyrocketed by 1,266.01% in 2023.
  • Over the past 5 years, Mimedx Group's Cash from Operations (Quarterly) stood at -$11.1 million in 2021, then surged by 49.44% to -$5.6 million in 2022, then soared by 264.83% to $9.3 million in 2023, then soared by 102.60% to $18.8 million in 2024, then soared by 49.45% to $29.3 million in 2025.
  • Its Cash from Operations was $29.3 million in Q3 2025, compared to $14.4 million in Q2 2025 and $5.3 million in Q1 2025.